Service Header - Pricing

Pricing & Negotiations

THE CORE OF MARKET ACCESS

Companies make major investments to develop and launch their medical innovations, which benefit both patients and the healthcare system. Prices must therefore be carefully justified and their value correctly demonstrated to stakeholders. To this end, MediTech Access can advise and fully support you in defining the best pricing strategy, upstream and during tariff negotiations with the competent authorities.

Pricing - European Scope

A EUROPEAN SCOPE

Various projects for selected countries — Some examples below

FRANCE

  • National reimbursement applications for medical device inscription on the LPPR, CCAM/NABM procedure code creation, LATM digital health solution applications.
  • Early funding applications: Forfait Innovation, PECT/PECAN, RIHN, Article 51, PHRC, PRME, ETAPES.
  • Local level: hospital listing applications (e.g. AP-HP/AGEPS/COMEDIMS).

BELGIUM

  • National reimbursement applications for medical devices (code creation on the List of Services or nominative list).
  • Early funding: ACL (limited clinical application), exceptional funding.

SWITZERLAND

  • CHOP procedure codes, Swiss-DRG codes or additional DRG funding.
  • Early access (Swiss-CED) or reimbursement applications (WZW), inpatient or outpatient TARMED/TARCO.
Pricing - Strategic View 360

A 360° STRATEGIC VIEW

High value-added strategy for sustainable reimbursement

  • In-depth understanding of the competitive landscape at national and European levels.
  • Evidence gap analysis against economic expectations of healthcare authorities.
  • Identification of key clinical and economic factors for early funding or reimbursement with sufficient tariff recognition, maintained long-term.
  • Identification of country-specific market access and health economic issues.
Pricing - Economic Tools

HIGH-LEVEL ECONOMIC TOOLS

For facilitated negotiations

  • In-depth coding analysis, with screening of health information systems and national medico-administrative databases (DRGs, nomenclatures, global budgets, funding modalities).
  • Strategic advice and support in medico-economic evidence generation (budget impact models, modelling, publications, sales support tools).
  • Complete production of value documents (economic notes, position papers) to facilitate negotiations with health authorities.
  • Definition and execution of an optimized pricing strategy with solid evidence-based argumentation.
Pricing - Long Term Support

COMPREHENSIVE LONG-TERM SUPPORT

For a relevant reimbursement tariff maintained throughout the lifecycle

  • In-depth advice, support and participation in interactions between the company and healthcare authorities (e.g. Ministry of Health, CEPS, hospitals).
  • Organization of workshops to best prepare tariff negotiations.
  • Direct negotiation with payers.
  • Continuous monitoring of the market access and regulatory environment to ensure long-term maintenance of reimbursement tariffs.

WE DO NOT END THERE.

SEE HOW WE CAN SUPPORT YOU.

Contact us